Zanubrutinib-induced aseptic meningitis: a case report and literature review

Zanubrutinib is a Bruton tyrosine kinase (BTK) inhibitor used in B cell malignancy treatment and is generally well tolerated in most patients. Zanubrutinib-induced aseptic meningitis is currently not reported. Herein, we present the first case of zanubrutinib-induced aseptic meningitis. A 33-year-ol...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jinjun Yang, Lian Wang, Xiao Zhong, Chenlu Yang, Yu Wu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2023-08-01
Serie:	Frontiers in Pharmacology
Soggetti:	Zanubrutinib bruton tyrosine kinase follicular lymphoma aseptic meningitis hematological diseases
Accesso online:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1242491/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!